Trodelvy 180 mg lyophilized powder for injection Images

Generic Name: sacituzumab govitecan

This medication has been identified as Trodelvy 180 mg lyophilized powder for injection. It is supplied by Gilead Sciences, Inc.

Trodelvy is used in the treatment of Breast Cancer and belongs to the drug class miscellaneous antineoplastics. Trodelvy 180 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Trodelvy

Generic Name

sacituzumab govitecan

Strength

180 mg lyophilized powder for injection

Availability

Prescription only

Drug Class

Miscellaneous antineoplastics

CSA Schedule

Not a controlled drug

Labeler / Supplier

Gilead Sciences, Inc.

National Drug Code (NDC)

55135-0132

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer